185 related articles for article (PubMed ID: 29859360)
1. Combined Diffuse Astrocytoma and Pleomorphic Xanthoastrocytoma Grade III Sharing IDH1 R132H Mutation.
Tourne M; Tauziède-Espariat A; Dezamis E; Saffroy R; Dhermain F; Chrétien F; Varlet P
World Neurosurg; 2018 Aug; 116():316-321. PubMed ID: 29859360
[TBL] [Abstract][Full Text] [Related]
2. Combined "Infiltrating Astrocytoma/Pleomorphic Xanthoastrocytoma" Harboring IDH1 R132H and BRAF V600E Mutations.
Yamada S; Kipp BR; Voss JS; Giannini C; Raghunathan A
Am J Surg Pathol; 2016 Feb; 40(2):279-84. PubMed ID: 26414224
[TBL] [Abstract][Full Text] [Related]
3. IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low-grade gliomas.
Liubinas SV; D'Abaco GM; Moffat BM; Gonzales M; Feleppa F; Nowell CJ; Gorelik A; Drummond KJ; O'Brien TJ; Kaye AH; Morokoff AP
Epilepsia; 2014 Sep; 55(9):1438-43. PubMed ID: 24903073
[TBL] [Abstract][Full Text] [Related]
4. Radiological and pathological features associated with IDH1-R132H mutation status and early mortality in newly diagnosed anaplastic astrocytic tumours.
Wasserman JK; Nicholas G; Yaworski R; Wasserman AM; Woulfe JM; Jansen GH; Chakraborty S; Nguyen TB
PLoS One; 2015; 10(4):e0123890. PubMed ID: 25849605
[TBL] [Abstract][Full Text] [Related]
5. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma.
Raghunathan A; Olar A; Vogel H; Parker JR; Coventry SC; Debski R; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Fuller GN
Ann Diagn Pathol; 2012 Aug; 16(4):255-9. PubMed ID: 22445362
[TBL] [Abstract][Full Text] [Related]
6. New IDH1 I113T mutation associated with BRAF V600E mutation: new driver of gliomagenesis?
Tabouret E; Fina F; Vincentelli F; Nanni I; Figarella-Branger D
J Neurol Sci; 2014 Jul; 342(1-2):204-6. PubMed ID: 24857351
[TBL] [Abstract][Full Text] [Related]
7. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
8. Analysis of NADP+-dependent isocitrate dehydrogenase-1/2 gene mutations in pediatric brain tumors: report of a secondary anaplastic astrocytoma carrying the IDH1 mutation.
Mascelli S; Raso A; Biassoni R; Severino M; Sak K; Joost K; Milanaccio C; Barra S; Grillo-Ruggieri F; Vanni I; Consales A; Cama A; Capra V; Nozza P; Garrè ML
J Neurooncol; 2012 Sep; 109(3):477-84. PubMed ID: 22821382
[TBL] [Abstract][Full Text] [Related]
9. C-terminally truncated form of αB-crystallin is associated with IDH1 R132H mutation in anaplastic astrocytoma.
Avliyakulov NK; Rajavel KS; Le KM; Guo L; Mirsadraei L; Yong WH; Liau LM; Li S; Lai A; Nghiemphu PL; Cloughesy TF; Linetsky M; Haykinson MJ; Pope WB
J Neurooncol; 2014 Mar; 117(1):53-65. PubMed ID: 24473683
[TBL] [Abstract][Full Text] [Related]
10. Ganglioglioma Progression to Combined Anaplastic Ganglioglioma and Anaplastic Pleomorphic Xanthoastrocytoma. Case Report and Literature Review.
Rosselló A; Plans G; Vidal-Sarró N; Fernández-Coello A; Gabarrós A
World Neurosurg; 2017 Dec; 108():996.e17-996.e25. PubMed ID: 28939541
[TBL] [Abstract][Full Text] [Related]
11. Finding of IDH1 R132H mutation in histologically non-neoplastic glial tissue changes surgical strategies, a case report.
Søndergaard CB; Scheie D; Sehested AM; Skjøth-Rasmussen J
Childs Nerv Syst; 2017 Jul; 33(7):1217-1220. PubMed ID: 28236063
[TBL] [Abstract][Full Text] [Related]
12. Value and limitations of immunohistochemistry and gene sequencing for detection of the IDH1-R132H mutation in diffuse glioma biopsy specimens.
Preusser M; Wöhrer A; Stary S; Höftberger R; Streubel B; Hainfellner JA
J Neuropathol Exp Neurol; 2011 Aug; 70(8):715-23. PubMed ID: 21760534
[TBL] [Abstract][Full Text] [Related]
13. KPNA2 predicts long term survival in patients with anaplastic oligoastrocytomas.
Gousias K; Niehusmann P; Gielen G; Simon M; Boström J
J Clin Neurosci; 2014 Oct; 21(10):1719-24. PubMed ID: 24929863
[TBL] [Abstract][Full Text] [Related]
14. BRAF V600E, TERT, and IDH2 Mutations in Pleomorphic Xanthoastrocytoma: Observations from a Large Case-Series Study.
Ma C; Feng R; Chen H; Hameed NUF; Aibaidula A; Song Y; Wu J
World Neurosurg; 2018 Dec; 120():e1225-e1233. PubMed ID: 30240866
[TBL] [Abstract][Full Text] [Related]
15. T2 mapping of the peritumoral infiltration zone of glioblastoma and anaplastic astrocytoma.
Auer TA; Kern M; Fehrenbach U; Tanyldizi Y; Misch M; Wiener E
Neuroradiol J; 2021 Oct; 34(5):392-400. PubMed ID: 33573473
[TBL] [Abstract][Full Text] [Related]
16. IDH1 mutation is prognostic for diffuse astrocytoma but not low-grade oligodendrogliomas in patients not treated with early radiotherapy.
Iwadate Y; Matsutani T; Hirono S; Ikegami S; Shinozaki N; Saeki N
J Neurooncol; 2015 Sep; 124(3):493-500. PubMed ID: 26243269
[TBL] [Abstract][Full Text] [Related]
17. IDH1 mutations in diffusely infiltrating astrocytomas: grade specificity, association with protein expression, and clinical relevance.
Thota B; Shukla SK; Srividya MR; Shwetha SD; Arivazhagan A; Thennarasu K; Chickabasaviah YT; Hegde AS; Chandramouli BA; Somasundaram K; Santosh V
Am J Clin Pathol; 2012 Aug; 138(2):177-84. PubMed ID: 22904127
[TBL] [Abstract][Full Text] [Related]
18. Spinal Cord Astrocytoma with Isocitrate Dehydrogenase 1 Gene Mutation.
Takai K; Tanaka S; Sota T; Mukasa A; Komori T; Taniguchi M
World Neurosurg; 2017 Dec; 108():991.e13-991.e16. PubMed ID: 28866063
[TBL] [Abstract][Full Text] [Related]
19. Secondary Glioblastoma: Molecular and Clinical Factors That Affect Outcome After Malignant Progression of a Lower Grade Tumor.
Gessler F; Zappi J; Konczalla J; Bernstock JD; Forster MT; Wagner M; Mittelbronn M; Seifert V; Senft C
World Neurosurg; 2017 Jun; 102():49-55. PubMed ID: 28263929
[TBL] [Abstract][Full Text] [Related]
20. Oligodendroglioma showing pleomorphic xanthoastrocytoma-like perivascular microlesion: With IDH1, TERT promoter mutation and 1p/19q codeletion detected in both components.
Murakami C; Ikota H; Nobusawa S; Nakata S; Yamazaki T; Hashiba Y; Hirato J; Yokoo H
Pathol Int; 2020 Jan; 70(1):40-46. PubMed ID: 31855307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
